Search Results - "Nowak, Joanna I."

  • Showing 1 - 13 results of 13
Refine Results
  1. 1

    Metabolic and Bioenergetic Alterations are Associated with Infection Susceptibility in Survivors of Severe Trauma: An Exploratory Study by Smith, Samuel R, Becker, Jr, Eugene J, Bone, Nathaniel B, Kerby, Jeffrey D, Nowak, Joanna I, Tadié, Jean-Marc, Darley-Usmar, Victor M, Pittet, Jean-Francois, Zmijewski, Jaroslaw W

    Published in Shock (Augusta, Ga.) (01-11-2024)
    “…Trauma and blood loss are frequently associated with organ failure, immune dysfunction, and a high risk of secondary bacterial lung infections. We aim to test…”
    Get full text
    Journal Article
  2. 2

    Protein Disulfide Isomerase Family A Member 3 Knockout Abrogate Effects of Vitamin D on Cellular Respiration and Glycolysis in Squamous Cell Carcinoma by Nowak, Joanna I, Olszewska, Anna M, Król, Oliwia, Żmijewski, Michał A

    Published in Nutrients (25-10-2023)
    “…PDIA3 is an endoplasmic reticulum disulfide isomerase, which is involved in the folding and trafficking of newly synthesized proteins. PDIA3 was also described…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs by Gorska-Arcisz, Monika, Popeda, Marta, Braun, Marcin, Piasecka, Dominika, Nowak, Joanna I, Kitowska, Kamila, Stasilojc, Grzegorz, Okroj, Marcin, Romanska, Hanna M, Sadej, Rafal

    Published in Cellular & molecular biology letters (14-05-2024)
    “…Genetic abnormalities in the FGFR signalling occur in 40% of breast cancer (BCa) patients resistant to anti-ER therapy, which emphasizes the potential of…”
    Get full text
    Journal Article
  6. 6

    VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH)2D3 in Squamous Cell Carcinoma Cells by Nowak, Joanna I., Olszewska, Anna M., Wierzbicka, Justyna M., Gebert, Magdalena, Bartoszewski, Rafał, Żmijewski, Michał A.

    Published in Cells (Basel, Switzerland) (01-01-2024)
    “…The genomic activity of 1,25(OH)2D3 is mediated by vitamin D receptor (VDR), whilst non-genomic is associated with protein disulfide isomerase family A member…”
    Get full text
    Journal Article
  7. 7

    Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH)2D3 in A431 squamous cell carcinoma by Olszewska, Anna M., Nowak, Joanna I., Myszczynski, Kamil, Słominski, Andrzej, Żmijewski, Michał A.

    Published in Molecular and cellular endocrinology (01-03-2024)
    “…BACKGROUNDHuman skin is the natural source, place of metabolism, and target for vitamin D3. The classical active form of vitamin D3, 1,25(OH)2D3, expresses…”
    Get full text
    Journal Article
  8. 8

    Different impact of vitamin D on mitochondrial activity and morphology in normal and malignant keratinocytes, the role of genomic pathway by Olszewska, Anna M., Nowak, Joanna I., Król, Oliwia, Flis, Damian, Żmijewski, Michał A.

    Published in Free radical biology & medicine (01-01-2024)
    “…Deregulation of mitochondria activity is one of the hallmarks of cancerogenesis and an important target for cancer therapy. Therefore, we compared the impact…”
    Get full text
    Journal Article
  9. 9

    PDIA3 modulates genomic response to 1,25-dihydroxyvitamin D3 in squamous cell carcinoma of the skin by Nowak, Joanna I., Olszewska, Anna M., Piotrowska, Anna, Myszczyński, Kamil, Domżalski, Paweł, Żmijewski, Michał A.

    Published in Steroids (01-11-2023)
    “…An active form of vitamin D3 (1,25-dihydroxyvitamin D3) acts through vitamin D receptor (VDR) initiating genomic response, but several studies described also…”
    Get full text
    Journal Article
  10. 10

    VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25[sub.2]D[sub.3] in Squamous Cell Carcinoma Cells by Nowak, Joanna I, Olszewska, Anna M, Wierzbicka, Justyna M, Gebert, Magdalena, Bartoszewski, Rafał, Żmijewski, Michał A

    Published in Cells (Basel, Switzerland) (01-12-2023)
    “…The genomic activity of 1,25(OH)[sub.2] D[sub.3] is mediated by vitamin D receptor (VDR), whilst non-genomic is associated with protein disulfide isomerase…”
    Get full text
    Journal Article
  11. 11

    Dissection of an impact of VDR and RXRA on the genomic activity of 1,25(OH) 2 D 3 in A431 squamous cell carcinoma by Olszewska, Anna M, Nowak, Joanna I, Myszczynski, Kamil, Słominski, Andrzej, Żmijewski, Michał A

    Published in Molecular and cellular endocrinology (01-03-2024)
    “…Human skin is the natural source, place of metabolism, and target for vitamin D . The classical active form of vitamin D , 1,25(OH) D , expresses pluripotent…”
    Get full text
    Journal Article
  12. 12

    VDR and PDIA3 Are Essential for Activation of Calcium Signaling and Membrane Response to 1,25(OH) 2 D 3 in Squamous Cell Carcinoma Cells by Nowak, Joanna I, Olszewska, Anna M, Wierzbicka, Justyna M, Gebert, Magdalena, Bartoszewski, Rafał, Żmijewski, Michał A

    Published in Cells (Basel, Switzerland) (20-12-2023)
    “…The genomic activity of 1,25(OH) D is mediated by vitamin D receptor (VDR), whilst non-genomic is associated with protein disulfide isomerase family A member 3…”
    Get full text
    Journal Article
  13. 13

    PDIA3 modulates genomic response to 1,25 - dihydroxyvitamin D 3 in squamous cell carcinoma of the skin by Nowak, Joanna I, Olszewska, Anna M, Piotrowska, Anna, Myszczyński, Kamil, Domżalski, Paweł, Żmijewski, Michał A

    Published in Steroids (05-08-2023)
    “…An active form of vitamin D (1,25-dihydroxyvitamin D ) acts through vitamin D receptor (VDR) initiating genomic response, but several studies described also…”
    Get full text
    Journal Article